iRadimed Corporation

32.78+0.9800+3.08%Vol 62.79K1Y Perf 12.53%
May 13th, 2022 16:00 DELAYED
BID30.03 ASK34.60
Open32.09 Previous Close31.80
Pre-Market- After-Market34.42
 - -  1.64 5.00%
Target Price
40.00 
Analyst Rating
Strong Buy 1.00
Potential %
22.03 
Finscreener Ranking
★★★★★     59.73
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★★     64.54
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     72.54
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
19.76 
Earnings Rating
Neutral
Market Cap411.72M 
Earnings Date
29th Apr 2022
Alpha0.02 Standard Deviation0.14
Beta0.98 

Today's Price Range

31.7133.50

52W Range

27.0855.92

5 Year PE Ratio Range

12.90969.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
5.00%
1 Month
-25.89%
3 Months
-32.97%
6 Months
-18.64%
1 Year
12.53%
3 Years
42.27%
5 Years
290.24%
10 Years
-

TickerPriceChg.Chg.%
IRMD32.780.98003.08
AAPL147.114.55003.19
GOOG2 330.3167.09002.96
MSFT261.125.77002.26
XOM88.862.56002.97
WFC42.640.83001.99
JNJ176.85-1.0200-0.57
FB198.627.38003.86
GE75.051.77002.42
JPM119.091.05000.89
Earnings HistoryEstimateReportedSurprise %
Q01 20220.180.2011.11
Q04 20210.180.3172.22
Q03 20210.150.2033.33
Q02 20210.120.120.00
Q01 20210.060.1183.33
Q04 20200.060.05-16.67
Q03 20200.020.09350.00
Q02 2020-0.07-0.17-142.86
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.20-76.74Negative
9/2022 QR0.21--
12/2022 FY0.89--
12/2023 FY1.11--
Next Report Date-
Estimated EPS Next Report0.18
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume62.79K
Shares Outstanding12.56K
Shares Float7.09M
Trades Count1.48K
Dollar Volume2.05M
Avg. Volume81.78K
Avg. Weekly Volume77.23K
Avg. Monthly Volume80.24K
Avg. Quarterly Volume87.88K

iRadimed Corporation (NASDAQ: IRMD) stock closed at 32.78 per share at the end of the most recent trading day (a 3.08% change compared to the prior day closing price) with a volume of 62.79K shares and market capitalization of 411.72M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 114 people. iRadimed Corporation CEO is Roger Susi.

The one-year performance of iRadimed Corporation stock is 12.53%, while year-to-date (YTD) performance is -29.06%. IRMD stock has a five-year performance of 290.24%. Its 52-week range is between 27.08 and 55.92, which gives IRMD stock a 52-week price range ratio of 19.76%

iRadimed Corporation currently has a PE ratio of 37.60, a price-to-book (PB) ratio of 6.27, a price-to-sale (PS) ratio of 8.44, a price to cashflow ratio of 33.60, a PEG ratio of 2.32, a ROA of 14.83%, a ROC of 13.39% and a ROE of 17.08%. The company’s profit margin is 23.21%, its EBITDA margin is 26.80%, and its revenue ttm is $44.90 Million , which makes it $3.57 revenue per share.

Of the last four earnings reports from iRadimed Corporation, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.18 for the next earnings report. iRadimed Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for iRadimed Corporation is Strong Buy (1), with a target price of $40, which is +22.03% compared to the current price. The earnings rating for iRadimed Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

iRadimed Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

iRadimed Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 10.44, ATR14 : 2.53, CCI20 : -55.82, Chaikin Money Flow : -0.10, MACD : -3.57, Money Flow Index : 33.70, ROC : -19.36, RSI : 36.81, STOCH (14,3) : 26.81, STOCH RSI : 1.00, UO : 46.21, Williams %R : -73.19), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of iRadimed Corporation in the last 12-months were: Anthony F. Vuoto (Option Excercise at a value of $0), Anthony F. Vuoto (Sold 3 690 shares of value $137 381 ), Chris Scott (Option Excercise at a value of $0), Chris Scott (Sold 70 000 shares of value $2 852 623 ), James B. Hawkins (Option Excercise at a value of $0), James B. Hawkins (Sold 157 500 shares of value $6 588 802 ), Monty Allen (Option Excercise at a value of $35 500), Monty Allen (Sold 5 597 shares of value $203 680 ), Roger Susi (Sold 360 000 shares of value $14 662 833 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

iRadimed Corporation

iRadimed Corp is a US-based company that mainly develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.

CEO: Roger Susi

Telephone: +1 407 677-8022

Address: 1025 Willa Springs Drive, Winter Springs 32708, FL, US

Number of employees: 114

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

71%29%

Bearish Bullish

75%25%

Bearish Bullish

70%30%

News

Stocktwits